(13:07) The history of discovering GLP-1s

(20:38) Impact of GLP-1s on different human functions

(27:09) Understanding the commercial aspect of drug discovery, pricing for GLP-1 drugs

(33:11) Responding to criticism and research of GLP-1 dependency

(40:04) Stock performance, dealing with political pressure related to successful drugs

(47:19) Eli Lilly's portfolio of drugs outside of GLP-1s, what science Dave is excited about

(56:09) Scaling and impacting culture at a 100+ year-old company